In addition, SGLT2is have been shown to reduce circulating levels of interleukin 6 (IL-6), tumor necrosis factor 1 (TNF-1) receptor, and matrix metalloproteinase-7 (MMP-7) and fibronectin-1, key molecules in the formation process of diabetic kidney disease [17]. Here, IL6 is linked to diabetic kidney disease.